Research and Development

Showing 15 posts of 9615 posts found.

pills-384846_960_720

Five worrying facts about fake medicine

March 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fake medicine, counterfeit medicine, falsified medicine

One million people die from fake drugs every year, with the worst continent being Africa where a suspected 200,000 die …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …
shutterstock_204190579

Cancer Research UK announces £10m pancreatic cancer project

March 24, 2017 Medical Communications, Research and Development Cancer Research UK, Pancreatic cancer

Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient …
mouse

Research found to reverse signs of ageing in mice

March 24, 2017 Medical Communications, Research and Development Aging

A new study has emerged that reveals another clue into the process of ageing and how, on a cellular level, …
george_masoura_drugdev_vice_president_business_development_europe_0

DrugDev signs up George Masoura as Vice President of Business Development

March 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …
shutterstock_146497481

GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles

March 23, 2017 Research and Development Biobank, GSK, Regeneron

GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …
shire_image

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017 Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …
fda2outsideweb

FDA approves first Parkinson’s treatment in a decade

March 22, 2017 Research and Development, Sales and Marketing FDA, Parkinson's, Xadago

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …
shutterstock_292920209

Alternative treatment cures rare blood disease for first time

March 22, 2017 Research and Development congenital dyserythropoietic anaemia

A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …
gsk_boronia_australia

GSK begins £92 million expansion of UK site

March 22, 2017 Manufacturing and Production, Research and Development GSK, UK

GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …
heartbeat

Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017 Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …

Novartis’ psoriasis drug allows some patients to go into remission

March 21, 2017 Research and Development Cosentyx, Novartis, psoriasis

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017 Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …
lilly_scientists

Lilly’s breast cancer drug meets primary endpoint

March 21, 2017 Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …

India aims to become “a global innovation hub” for biotechs by 2020

March 21, 2017 Manufacturing and Production, Research and Development India, biotech

The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …
The Gateway to Local Adoption Series

Latest content